GORDON RESEARCH CONFERENCE ON CATECHOLAMINES

描述(摘自申请者的摘要)：这是一份会议补助金 请求对1997年GRCC提供支持。本次会议将于7月20日至25日举行， 1997年，在新罕布夏州安多弗的普罗科特学院。主席将由Dr。 南希·扎尼瑟和副主席将由玛丽-弗朗索瓦·切塞特博士担任。 组委会其他成员包括加里·S·阿斯顿-琼斯博士， Marc G.Caron博士、Dona M.Chikaraishi博士、Ian Creese博士、Barry J. 霍弗博士、贝丝·J·霍夫曼博士、罗伯特·B·英尼斯博士、丹尼斯·杰克逊博士、 李·林伯德、丹尼森·A·史密斯博士和迈克尔·J·齐格蒙德博士。这个 重点将放在讨论前沿、未发表的研究上 儿茶酚胺领域，将包括与两到三名演讲者和 讨论者，在“海报子弹”演示之前的海报会议 (大多数与会者将提交一张海报)，圆桌会议 讨论小组，以及林伯德博士的全体演讲。会议将于 规模较小(约125人)；然而，组委会 将努力确保不同的初级和高级群体 调查人员出席。每堂课至少有一位演讲者是 初级调查员。鼓励学生和博士后研究员 来参加。因此，这次会议将是一个科学的和 培训功能。会议将重点讨论“文字法规”。 儿茶酚胺基因“，”转运蛋白：新的特性和调节“， 《纹状体外多巴胺系统和运动障碍》、《受体、激酶》 和渠道“，”毒瘾、精神病和麻醉：新 《洞察》、《中枢去甲肾上腺素系统》、《转基因、基因敲除和 “行为”、“发育、衰老和可塑性”以及“外围” 去甲肾上腺素系统：心力衰竭“，学生/博士后生涯 由齐格蒙德博士和史密斯博士主持的“机会”研讨会将是 这是该计划的重要新成员。所要求的财政支持将 用于增加参与这一活动的妇女和少数族裔的人数 开会。

DESCRIPTION (Adapted from applicant's abstract): This is a conference grant requesting support for the 1997 GRCC. This meeting will be held July 20-25, 1997, at the Proctor Academy, Andover, New Hampshire. The Chair will be Dr. Nancy Zahniser and the Vice-Chair will be Dr. Marie-Francoise Chesselet. Other members of the Organizing Committee include Dr. Gary S. Aston-Jones, Dr. Marc G. Caron, Dr. Dona M. Chikaraishi, Dr. Ian Creese, Dr. Barry J. Hoffer, Dr. Beth J. Hoffman, Dr. Robert B. Innis, Dr. Denise Jackson, Dr. Lee Limbird, Dr. Dennison A. Smith, and Dr. Michael J. Zigmond. The emphasis will be on discussion of cutting-edge, unpublished research in the catecholamine field and will include sessions with two or three speakers and a discussant, poster sessions preceded by "poster bullet" presentations (most participants will be expected to present a poster), roundtable discussion groups, and a plenary lecture by Dr. Limbird. The meeting will be small (approximately 125 participants); however, the Organizing Committee will strive to insure that a diverse group of both junior and senior investigators attends. At least one speaker in each session will be a junior investigator. Students and postdoctoral fellows will be encouraged to attend. Therefore, the conference will serve both a scientific and training function. Sessions will focus on "Transcriptional Regulation of Catecholamine Genes", "Transporters: Novel Properties and Regulation", "Extrastriatal Dopamine Systems and Movement Disorders", "Receptors, Kinases and Channels", "Drug Addiction, Mental Illness and Anesthesia: New Insights", "Central Noradrenergic Systems", "Transgenics, Knockouts, and Behavior", "Development, Aging, and Plasticity", and "Peripheral Noradrenergic Systems: Heart Failure". A Student/Postdoc Career Opportunities" Workshop, chaired by Dr. Zigmond and Dr. Smith will be an important new addition to the program. The financial support requested will be used to increase the number of women and minorities participating in this meeting.